NCT03193957View on ClinicalTrials.gov

An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

August 3, 2017

Study Completion Date

September 25, 2017

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Etanercept

Etanercept PFS and Autoinjector

DEVICE

Autoinjector

Trial Locations (1)

Unknown

AI Centrum Medyczne, Poznan

All Listed Sponsors

lead

Samsung Bioepis Co., Ltd.

INDUSTRY

NCT03193957 - An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter